Jul 13, 2016
The findings in the study are relevant for the US, India, Pakistan, and many other countries, low-, middle-, and high-income countries alike where achievement of diabetes care goals is suboptimal and where health disparities are common.
New Delhi: Led by leading researchers at the Public Health Foundation of India, All India Institute of Medical Sciences, and Emory University (Atlanta, USA), a new trial at ten clinical centers in India and Pakistan has shown that a low-cost care model can help patients with diabetes double their likelihood of controlling their disease.
The study paper is titled, ‘Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals: A Randomized Controlled Trial’.
This was the first trial of comprehensive diabetes management in a low/middle-income country setting. Of the 415 million people with diabetes worldwide, 75% live in low/middle-income countries. India alone is home to the second highest number of people with diabetes [nearly 70 million] worldwide.
This intervention doesn’t require new or expensive drugs, but instead enhances patients’ likelihood of managing their disease on their own by providing individualized support and enhancing the physician’s likelihood of being responsive.
The intervention yielded sizeable improvements in blood sugar, blood pressure, and cholesterol profiles of participants, using this low-cost approach.
This major collaborative study was funded by the US National Institutes of Health and shows the value that can be gained from global collaborations in research to improve health.